[1] Bergrem H,Danielson B G,Eckardt K U,et al. A case of antierythropoiet in antibodies following recombinant human erythropoietin treatment[M]. Erythropoietin:molecular physiology and clinical application,New York,Marcel Dekker,1993:266-275.
[2] Casadevall N, Nataf J, Viron B,et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin[J].N Engl J Med, 2002, 346(7)：469-475.
[3] Storring P L, Tiplady R J, Gaines Das R E , et al.Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties[J].Br J Haematol, 1998 ,100(1):79-89.
[4] Casadevall N. Pure red cell aplasia and anti-erythropoietin antibodiesin patients treated with epoetin[J].Nephrol Dial Transplant,2003,18(8):37-41.
[5] Gershon S K, Luksenburg H, Coté T R,et al. Pure red-cell aplasia and recombinant erythropoietin[J]. N Engl J Med,2002,346(20):1584-1592.
[6] Weber G, Gross J,Kromnfinga A, et al. Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins[J].J Am Soc Nephrol,2002,13(9):2381-2383.
[7] 陈香美, 冯全洲. 促红细胞生成素引起纯红细胞再生障碍性贫血[J]. 药物不良反应杂志,2004,6(2):95-96. |
